Polymalformative genetic syndrome with increased risk of developing cancer

Polymalformative genetic syndrome with increased risk of developing cancer (Orphanet code 183422) is a broad classification category within Orphanet that encompasses a group of rare genetic conditions characterized by the combination of multiple congenital malformations (polymalformative features) and a significantly elevated predisposition to developing various types of cancer. This grouping includes numerous distinct syndromes in which affected individuals are born with structural abnormalities involving multiple organ systems — such as the skeletal system, skin, nervous system, cardiovascular system, and genitourinary tract — alongside a hereditary susceptibility to benign and/or malignant tumors. Because this is a classification group rather than a single disease entity, the specific clinical features, inheritance patterns, and cancer risks vary widely depending on the underlying syndrome. Examples of conditions that fall under this umbrella include syndromes such as Gorlin syndrome, Beckwith-Wiedemann syndrome, Costello syndrome, and others where developmental anomalies co-occur with tumor predisposition. Patients within this category typically require multidisciplinary care involving geneticists, oncologists, and specialists relevant to their specific malformations. Cancer surveillance protocols are tailored to the particular syndrome and its associated tumor spectrum. Treatment approaches are syndrome-specific and generally focus on surgical correction or management of congenital malformations, enhanced cancer screening programs for early detection, and standard oncologic therapies when cancers develop. Genetic counseling is essential for affected individuals and their families to understand recurrence risks and guide surveillance strategies.

Common questions about Polymalformative genetic syndrome with increased risk of developing cancer